Risk of Mortality Associated With Pimavanserin Use Compared With Other Atypical Antipsychotics in Patients With Parkinson’s Disease–Related Psychosis

Documents

Study protocol

Initial protocol

0305976 PDP ACADIA mortality protocol 13AUG2021_signed_redacted

Study results

No information provided.

Study report

No information provided.

Publications

Study publications

Layton JB, Forns J, McQuay LJ, Danysh HE, Dempsey C, Anthony MS, Turner ME. Mor…

Layton JB, McQuay L, Forns J, Danysh H, Dempsey C, Anthony M, Turner ME. Risk o…

Rao S, McQuay LJ, Forns J, MacKay R, Danysh HE, Doshi D, Abler V, Anthony MS, L…

Rao S, McQuay LJ, Forns J, MacKay R, Aquilina TC, Doshi D, Abler V, Anthony MS,…

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.